iCAD nets 510(k) for interventional breast MRI app

Sarah Lamberti | | Health Imaging | Breast MRI
The FDA has granted 510(k) clearance to iCAD for PrecisionPoint, its interventional planning solution for breast MRI that will be offered as an integrated module within the company's CADvue breast MRI image review software.

CADvue is an MRI image review, analysis and BI-RADS compatible reporting solution that generates contrast enhancement curves, dynamic 3D images and quantification of key lesion parameters. CADvue's automation of critical manual steps reduces the time required to generate curves and streamlines radiologists' work flow and diagnosis, according to iCAD.

The company said that the addition of PrecisionPoint, coupled with the new features and product enhancements within CADvue, will give clinicians a set of tools to improve the review and analysis of breast MRI studies, as well as interventional planning.

Sarah Lamberti

Related Content

AI model spots up to 30% of breast cancers missed on MRI
Breast cancer only visible via MRI is often less aggressive
The pros and cons of current breast screening modalities and the role of AI
AI tool's supplemental MRI recs help detect 4 times more breast cancers than density measures
Applying Node-RADS to breast MRI exams improves staging
New study results 'strongly' back supplemental MRI for women with dense breasts

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.